Satenig Guler
Ono Pharmaceutical (United States)(US)Research & Development Institute(US)Merck Serono (Italy)(IT)
Publications by Year
Research Areas
Biochemical and Molecular Research, Cancer therapeutics and mechanisms, Tuberculosis Research and Epidemiology, Antibiotic Resistance in Bacteria, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii(2017)267 cited
- → Rational design of a new antibiotic class for drug-resistant infections(2021)137 cited
- → Antibacterial Inhibitors of Gram-Positive Thymidylate Kinase: Structure–Activity Relationships and Chiral Preference of a New Hydrophobic Binding Region(2014)61 cited
- → Discovery of Selective and Potent Inhibitors of Gram-Positive Bacterial Thymidylate Kinase (TMK)(2012)54 cited
- → Inhibitors of Tumor Progression Loci-2 (Tpl2) Kinase and Tumor Necrosis Factor α (TNF-α) Production: Selectivity and in Vivo Antiinflammatory Activity of Novel 8-Substituted-4-anilino-6-aminoquinoline-3-carbonitriles(2007)45 cited
- → In Vivo Validation of Thymidylate Kinase (TMK) with a Rationally Designed, Selective Antibacterial Compound(2012)44 cited